• In March 2026, Science Applications International Corporation reported fourth-quarter and full-year 2026 results showing slightly lower quarterly sales and net income, reiterated fiscal 2027 revenue guidance of US$7.0 billion to US$7.2 billion, completed a large share repurchase under its existing authorization, filed an ESOP-related shelf registration, and affirmed a US$0.37 quarterly dividend.
• Together, these actions highlight SAIC’s focus on returning capital through buybacks and dividends while maintaining employee ownership incentives and revenue guidance stability.
• Next, we will examine how SAIC’s reaffirmed revenue guidance interacts with its existing investment narrative and expectations for future cash flows.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Science Applications International Investment Narrative Recap

To own SAIC, you generally need to believe the company can translate its federal IT and engineering contracts into steady cash flows despite contract timing and budget uncertainty. The latest quarter’s modest revenue and earnings declines, combined with reaffirmed fiscal 2027 revenue guidance, do not materially change that near term. The main near term catalyst remains how quickly funding and awards normalize, while the biggest risk is continued pressure from government efficiency efforts and contract delays.

Among the recent announcements, the completion of a large share repurchase under the US$1.2 billion authorization stands out. Retiring 16.72% of shares for about US$829.16 million tightens the share base that future earnings and cash flows will be spread over, which can be important when guidance implies relatively flat revenues. For investors watching SAIC’s contract wins and funding environment, this capital return policy sits alongside guidance as a key part of the near term story.

Yet behind the steady dividend and buybacks, investors should also be aware of how contract losses and shifting government priorities could...

Science Applications International's narrative projects $7.7 billion revenue and $344.8 million earnings by 2028. This requires 1.0% yearly revenue growth and a $54.2 million earnings decrease from $399.0 million today.

Uncover how Science Applications International's forecasts yield a $113.38 fair value, a 17% upside to its current price.

Exploring Other Perspectives

Before this news, the most cautious analysts were assuming roughly flat revenue around US$7.5 billion and earnings near US$412 million by 2028, so if you worry about book to bill weakness and NASA program losses, their more pessimistic view offers a useful counterweight that could shift again as new results and guidance emerge.

Explore 3 other fair value estimates on Science Applications International - why the stock might be worth just $113.38!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Science Applications International research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Science Applications International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Science Applications International's overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.